Efficacy and Safety of PARP Inhibitor Combination Therapy in Recurrent Ovarian Cancer: A Systematic Review and Meta-Analysis

OBJECTIVES: Though it is known to all that PARP inhibitors (PARPis) are effective when used as maintenance alone for women with recurrent ovarian cancer (ROC), little is known about whether using them in combination with other drugs would contribute to a better efficacy. We performed a systematic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Ning, Zhang, Leyin, Yu, Jieru, Guan, Siqi, Dai, Xinyang, Sun, Leitao, Ying, Minli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414886/
https://www.ncbi.nlm.nih.gov/pubmed/34485111
http://dx.doi.org/10.3389/fonc.2021.638295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414886/
https://www.ncbi.nlm.nih.gov/pubmed/34485111
http://dx.doi.org/10.3389/fonc.2021.638295

Ejemplares similares